ATE331791T1 - Phosphodiesterase 10 - Google Patents
Phosphodiesterase 10Info
- Publication number
- ATE331791T1 ATE331791T1 AT99934307T AT99934307T ATE331791T1 AT E331791 T1 ATE331791 T1 AT E331791T1 AT 99934307 T AT99934307 T AT 99934307T AT 99934307 T AT99934307 T AT 99934307T AT E331791 T1 ATE331791 T1 AT E331791T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptides
- pde10
- polynucleotides
- binding partners
- expression constructs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7550898P | 1998-02-23 | 1998-02-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE331791T1 true ATE331791T1 (de) | 2006-07-15 |
Family
ID=22126229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99934307T ATE331791T1 (de) | 1998-02-23 | 1999-02-23 | Phosphodiesterase 10 |
Country Status (8)
Country | Link |
---|---|
US (4) | US6350603B1 (de) |
EP (1) | EP1060251B1 (de) |
JP (1) | JP2002504341A (de) |
AT (1) | ATE331791T1 (de) |
AU (1) | AU3307999A (de) |
CA (1) | CA2321224A1 (de) |
DE (1) | DE69932153T2 (de) |
WO (1) | WO1999042596A2 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1223937A2 (de) * | 1999-10-07 | 2002-07-24 | Novaneuron Inc. | Gen notwendung für striatale funktion, dessen verwendung, und verbindungen zur modulierung desselben |
AU7999300A (en) * | 1999-10-07 | 2001-05-10 | Zymogenetics Inc. | Novel human phosphodiesterase zcytor13 |
US20040152106A1 (en) * | 1999-10-07 | 2004-08-05 | Robertson Harold A. | Gene necessary for striatal function, uses thereof, and compounds for modulating same |
WO2002083883A2 (en) * | 2001-04-11 | 2002-10-24 | Altana Pharma Ag | Human phosphodiesterase 9a isoform |
IL149106A0 (en) * | 2001-04-20 | 2002-11-10 | Pfizer Prod Inc | Therapeutic use of selective pde10 inhibitors |
EP1666886A3 (de) * | 2001-04-20 | 2006-06-21 | Pfizer Products Inc. | Verfahren zur Identifizierung eines selektiven PDE10 Hemmers |
EP1321034A1 (de) * | 2001-12-21 | 2003-06-25 | Pfizer Products Inc. | Unterbrechung des Phosphodiesterase 10 Gens |
WO2004044235A1 (en) * | 2002-11-13 | 2004-05-27 | Bayer Healthcare Ag | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A1 (PDE7a1) |
WO2004053494A1 (en) * | 2002-12-09 | 2004-06-24 | Bayer Healthcare Ag | DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) |
EP1573332A1 (de) * | 2002-12-09 | 2005-09-14 | Bayer HealthCare AG | Diagnostik und therapie für krankheiten, die mit humane phosphodiesterase 9a3 (pde9a3) assoziiert sind |
US20060166316A1 (en) * | 2003-04-03 | 2006-07-27 | Memory Pharmaceuticals Corporation | Phosphodiesterase 10a7 isoforms and methods of use |
CA2604349A1 (en) * | 2005-02-28 | 2006-09-08 | Nycomed Gmbh | Method for identifying pde10 modulators |
US7446345B2 (en) * | 2005-04-29 | 2008-11-04 | Cree, Inc. | Light emitting devices with active layers that extend into opened pits |
JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
WO2007129183A2 (en) | 2006-05-02 | 2007-11-15 | Pfizer Products Inc. | Bicyclic heteroaryl compounds as pde10 inhibitors |
US7786139B2 (en) | 2006-11-21 | 2010-08-31 | Omeros Corporation | PDE10 inhibitors and related compositions and methods |
WO2008079111A1 (en) * | 2006-12-20 | 2008-07-03 | Carrier Corporation | Method for determining refrigerant charge |
US8637528B2 (en) | 2007-03-27 | 2014-01-28 | Omeros Corporation | Use of PDE7 inhibitors for the treatment of movement disorders |
CN101917992A (zh) * | 2007-03-27 | 2010-12-15 | 奥默罗斯公司 | 用于治疗运动障碍的pde7抑制剂的用途 |
US20150119399A1 (en) | 2012-01-10 | 2015-04-30 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3027279A1 (de) * | 1980-07-18 | 1982-05-06 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Substituierte adenosin-3',5'-phosphorsaeurebenzyltriester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE69034135T3 (de) | 1989-12-22 | 2012-08-23 | Laboratoires Serono S.A. | DNS-Konstrukten zur Aktivierung und Veränderung der Expression von endogenen Genen |
JP3354149B2 (ja) * | 1991-04-19 | 2002-12-09 | ザ ボード オブ リージェンツ オブ ザ ユニヴァーシテイ オブ ワシントン | 哺乳類ホスホジエステラーゼをコードするdna |
EP0539573A4 (en) | 1991-05-15 | 1993-12-29 | Cell Genesys, Inc. | Genomic modifications with homologous dna targeting |
TW402639B (en) | 1992-12-03 | 2000-08-21 | Transkaryotic Therapies Inc | Protein production and protein delivery |
ATE438723T1 (de) * | 1993-05-27 | 2009-08-15 | Univ Washington | Cyclisch gmp bindende cyclisch gmp spezifische phosphodiesterase materialien und verfahren |
GB9518220D0 (en) | 1995-09-06 | 1995-11-08 | Medical Res Council | Checkpoint gene |
US5798246A (en) * | 1996-03-25 | 1998-08-25 | Incyte Pharmaceuticals, Inc. | Cyclic nucleotide phosphodiesterase |
US5922595A (en) | 1997-12-09 | 1999-07-13 | Incyte Pharmaceuticals, Inc. | Cyclic GMP phosphodiesterase |
-
1999
- 1999-02-23 CA CA002321224A patent/CA2321224A1/en not_active Abandoned
- 1999-02-23 US US09/256,000 patent/US6350603B1/en not_active Expired - Fee Related
- 1999-02-23 WO PCT/US1999/003879 patent/WO1999042596A2/en active IP Right Grant
- 1999-02-23 AU AU33079/99A patent/AU3307999A/en not_active Abandoned
- 1999-02-23 JP JP2000532536A patent/JP2002504341A/ja active Pending
- 1999-02-23 AT AT99934307T patent/ATE331791T1/de not_active IP Right Cessation
- 1999-02-23 DE DE69932153T patent/DE69932153T2/de not_active Expired - Fee Related
- 1999-02-23 EP EP99934307A patent/EP1060251B1/de not_active Expired - Lifetime
-
2001
- 2001-12-20 US US10/034,015 patent/US6734003B2/en not_active Expired - Fee Related
-
2002
- 2002-02-26 US US10/083,620 patent/US6864070B2/en not_active Expired - Fee Related
-
2004
- 2004-05-11 US US10/842,965 patent/US20050009062A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030044950A1 (en) | 2003-03-06 |
EP1060251B1 (de) | 2006-06-28 |
DE69932153D1 (en) | 2006-08-10 |
CA2321224A1 (en) | 1999-08-26 |
AU3307999A (en) | 1999-09-06 |
US6864070B2 (en) | 2005-03-08 |
JP2002504341A (ja) | 2002-02-12 |
EP1060251A2 (de) | 2000-12-20 |
US20050009062A1 (en) | 2005-01-13 |
WO1999042596A2 (en) | 1999-08-26 |
DE69932153T2 (de) | 2007-05-31 |
US6350603B1 (en) | 2002-02-26 |
US20030148378A1 (en) | 2003-08-07 |
WO1999042596A3 (en) | 2000-03-02 |
US6734003B2 (en) | 2004-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE331791T1 (de) | Phosphodiesterase 10 | |
IL175698A0 (en) | Phosphodiesterase 8a | |
WO1996034107A3 (en) | Antiviral proteins, dna coding sequences therefor, and uses thereof | |
DK1131444T3 (da) | Polypeptider med lysophospholipase aktivitet og nucleinsyre som koder for disse | |
ZA987491B (en) | Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation | |
WO1998058052A3 (en) | Disease associated protein kinases | |
WO1999058692A3 (en) | Human apoptosis associated proteins | |
DE69837475D1 (de) | Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren | |
WO2003055908A3 (en) | Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases | |
WO2001007471A3 (en) | Cell cycle and proliferation proteins | |
DK0935652T3 (da) | Keratinocyt vækstfaktor-2 produkter | |
WO1999031128A3 (en) | Human tumor necrosis factor-r2-like proteins | |
WO2001085961A3 (en) | Human caspase-12 | |
WO2000023589A3 (en) | Proliferation and apoptosis related proteins | |
WO2000028045A3 (en) | Human hydrolase proteins | |
DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
WO1999038981A3 (en) | Human protein kinase molecules | |
DE69934017D1 (de) | 2,6-beta-d-fruktanhydrolase enzym und verfahren zu dessen verwendung | |
WO1999031225A3 (en) | Human phosphatases | |
WO1999027080A3 (en) | Human protein kinase and kinase inhibitors | |
WO2001012790A3 (en) | Isomerase proteins | |
WO1998057986A3 (en) | Human preprotachykinin b | |
AU7139501A (en) | Control of metabolism with compositions of the human 2-oxoglutarate carrier | |
WO1999043829A3 (en) | Cell cycle related proteins | |
WO2000023466A3 (en) | Human rna binding proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |